Brunton TL. On the use of nitrate of amyl in angina pectoris. Lancet 1867;2:9–98.
Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:37–376.
Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:52–526.
Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:73–749.
Ignarro LJ. Biosynthesis and metabolism of endotheliumderived nitric oxide. Annu Rev Pharmacol Toxicol 1990;30:53–560.
Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:10–142.
Luscher TF. Endogenous and exogenous nitrates and their role in myocardial ischemia. Br J Clin Pharmacol 1992;34(Suppl 1):29S-35S.
Culotta E, Korschland DE Jr. NO news is good news. Science 1992:258:186–1865.
Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992;258:189– 1902.
Radomski MW, Palmer RM, Moncada S. The antiaggregating properties of vascular endothelium: Interaction between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:63–646.
Radomski MW, Palmer RM, Moncada S. An l-arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:519–5197.
Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMPdependent pathways by nitric oxide in cardiac myocytes. Circ Res 1999;84:102–1031.
Recchia FA, McConnell PI, Bernstein RD, Vgel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998;83:96–979.
Murell W. Nitroglycerin as a remedy for angina pectoris. Lancet 1879;1:8–81, 11–115, 11–122, 22–227.
Jugdutt BI. Myocardial salvage by intravenous nitroglycerin in conscious dogs: Loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation 1983;68:67–684.
Jugdutt BI, Warnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications. Effect of timing, dosage and infarct location. Circulation 1988;78:90–919.
Jugdutt BI, Warnica JW. Tolerance with low dose intravenous nitroglycerin therapy in acute myocardial infarction. Am J Cardiol 1989;64:58–587.
Jugdutt BI. Intravenous nitroglycerin unloading in acute myocardial infarction. Am J Cardiol 1991;68:52D-62D.
Stewart DD. Remarkable tolerance to nitroglycerine. Philadelphia Polyclinic 1888;6:43.
Prodger SH, Ayman D. Harmful effects of nitroglycerin: With special reference to coronary thrombosis. Am J Med Sci 1932;184:48–491.
Imhof PR, Ott B, Frankhauser P, Chu LC, Hodler J. Difference in nitroglycerin dose-response in the venous and arterial beds. Eur J Clin Pharmacol 1980;18:45–460.
Jugdutt BI. Nitrates in myocardial infarction. Cardiovasc Drugs Ther 1994;8:63–616.
Fye WB. Nitroglycerin: A homeopathic remedy. Circulation 1986;73:2–29.
Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemiareperfusion. J Pharmacol Exp Ther 1992;260:66–675.
Johnson G 3rd, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991;19:24–252.
Keefer LK. Nitric oxide-releasing compounds: From basic research to promising drugs. Mod Drug Discov 1998;1:2–30.
Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure. Potentiation of ?-adrenergic inotropic responsiveness. Circulation 1998;97:16–166.
Andrews KL, Triggle CR, Ellis A. NO in the vasculature: Where does it come from and what does it do? Heart Fail Rev 2002;7:42–445.
Paulus WJ, Bronzwaer JGF. Myocardial contractile effects of nitric oxide. Heart Fail Rev 2002;7:37–383.
Wollert K, Drexler H. Regulation of cardiac remodeling by nitric oxide: Focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev 2002;7:31–325.
Oyama J, Frantz S, Blais C, Kelly RA, Bourcier T. Nitric oxide, cell death, and heart failure. Heart Fail Rev 2002;7:32–334.
Mungrue IN, Husain M, Stewart DJ. The role of NOS in heart failure: Lessons from murine genetic models. Heart Fail Rev 2002;7:40–422.
Lalu MM, Wang W, Schultz R. Peroxynitrite in myocardial ischemia-reperfusion injury. Heart Fail Rev 2002;7:35–369.
de Gasparo M. Angiotensin II and nitric oxide interaction. Heart Fail Rev 2002;7:34–358.
Warnholtz A, Tsilimingas N, Wendt M, Munzel T. Mechanisms underlying nitrate-induced endothelial dysfunction: Insight from experimental and clinical studies. Heart Fail Rev 2002;7:33–345.
Jugdutt B. NO and cardioprotection during ischemiareperfusion. Heart Fail Rev 2002;7:39–405.